Viewing Study NCT03349203


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT03349203
Status: UNKNOWN
Last Update Posted: 2018-07-18
First Post: 2017-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module